Skip to main content

Balchem Corporation Value Stock - Dividend - Research Selection

Balchem corporation

ISIN: US0576652004 , WKN: 905650

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

2025-12-26

Statement on new EU choline chloride anti-dumping measures

2025-12-22
EU producers laud EU for addressing choline chloride dumping by China; measures will help preserve jobs and secure feed supply chainMONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and 115.9% on choline chloride imports from the People's Republic of China. This decision, which will be effective for five years with the poss

Dividend Champion, Contender, And Challenger Highlights: Week Of December 21

2025-12-19
Get the latest weekly summary on dividend changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers.

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

2025-12-13
Key Insights Balchem's estimated fair value is US$156 based on 2 Stage Free Cash Flow to Equity With US$156 share...

Balchem Director Sells 8,000 Shares for $1.2 Million a Week Before a Dividend Hike

2025-12-12
Balchem, a leader in specialty ingredients serving the food, pharmaceutical, and animal health markets, just reported insider selling activity.

Balchem Corporation Announces Dividend

2025-12-10
MONTVALE, N.J., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2025, its Board of Directors declared a dividend on its shares of common stock equal to $0.96 per share on the Company’s issued and outstanding Common Stock, to be payable on January 20, 2026 to stockholders of record at the close of business on December 23, 2025. This dividend represents an 10.3% increase over last year’s annual dividend. Ted Harris, Balchem’s Chairman, Presi

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

2025-11-29
Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages. Check out the upcoming dividend increases.

Balchem Corporation's (NASDAQ:BCPC) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

2025-11-14
Balchem's (NASDAQ:BCPC) stock is up by a considerable 10% over the past month. Since the market usually pay for a...

Balchem Corporation to Present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025

2025-10-30
MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations, will present at the conference. About Balchem Corporation

Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)

2025-10-23
Balchem stock is upgraded to "Buy" as strong Q3 results and emerging food trends signal growth. Here's what investors need to know about BCPC stock.